Regencell Bioscience Holdings Balance Sheet Health
Financial Health criteria checks 6/6
Regencell Bioscience Holdings has a total shareholder equity of $8.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $8.4M and $219.5K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$7.96m |
| Equity | US$8.22m |
| Total liabilities | US$219.51k |
| Total assets | US$8.44m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: RGC's short term assets ($8.1M) exceed its short term liabilities ($193.6K).
Long Term Liabilities: RGC's short term assets ($8.1M) exceed its long term liabilities ($25.9K).
Debt to Equity History and Analysis
Debt Level: RGC is debt free.
Reducing Debt: RGC currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RGC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: RGC has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 46.6% each year.